What kind of data should you collect prior to blood transfusion?

1. Bellamy RF, Maningas PA, Wenger BA. Current shock models and clinical correlations. Ann Emerg Med. 1986;15:1392. [PubMed] [Google Scholar]

2. Runciman WB, Sjowronski GA. Pathophysiology of hemorrhagic shock. Anaesth Intensive Care. 1984;12:193–205. [PubMed] [Google Scholar]

3. Dutton RP. Smith CE, Rosenberg AD, Grande CM, editors. Pathophysiology of traumatic shock. Massive transfusion and control of hemorrhage in the trauma patient. Seminars in Anaesthesia, Perioperative medicine and pain. 2001;Vol 20:7–10. [Google Scholar]

4. Peitzman AB, Billiar TR, Harbrecht BG, Kelly E, Udekwu AD, Simmons RL. Hemorrhagic shock. Curr Probl Surg. 1995;32:925–1002. [PubMed] [Google Scholar]

5. Moore EE. Staged laparotomy for the hypothermia, acidosis, coagulopathy syndrome. Am J Surg. 1996;72:405–10. [PubMed] [Google Scholar]

6. Riddez L, Johnson L, Hahn RG. Central and regional hemodynamics during crystalloid fluid therapy after uncontrolled intra abdominal bleeding. J Trauma. 1998;44:433–9. [PubMed] [Google Scholar]

7. Shaftan GW, Chiu C, Dennis C, Harris B. Fundamentals of physiologic control of arterial hemorrhage. Surgery. 1965;58:851–6. [PubMed] [Google Scholar]

8. Bickell WH, Wall MJ, Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, et al. Immediate versus delayed resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331:1105–9. [PubMed] [Google Scholar]

9. Solomonov E, Hirsh M, Yahiya A, Krausz MM. The effect of vigorous fluid resuscitation in uncontrolled hemorrhagic shock after massive splenic injury. Crit Care Med. 2000;28:749–54. [PubMed] [Google Scholar]

10. Wagner BK, D’Amelio LF. Pharmacologic and clinical consideration in selecting crystalloid, colloidal and oxygen carrying resuscitation fluids. Clin Pharm. 1993;12:335–46. [PubMed] [Google Scholar]

11. Funk W, Baldinger V. Microcirculatory perfusion during volume therapy. A comparative study using crystalloid or colloid in awake animals. Anaesthesiology. 1995;82:975–82. [PubMed] [Google Scholar]

12. Krausz MM, Bashenoko Y. Hirsh M Crystalloid and colloid resuscitation of uncontrolled hemorrhagic shock following massive splenic injury. Shock. 2001;16:383–8. [PubMed] [Google Scholar]

13. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2007;4:CD000567. [PubMed] [Google Scholar]

14. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev. 2008;1:CD001319. [PubMed] [Google Scholar]

15. Chen S, Zhu X, Wang Q, Li W, Cheng D, Lei C, et al. The early effect of Voluven, a novel hydroxyethyl starch on cerebral oxygen supply and consumption in resuscitation of rabbit with acute hemorrhagic shock. J Trauma. 2009;66:676–82. [PubMed] [Google Scholar]

16. Angele MK, Schneider CP, Chaudry IH. Bench to bedside review: latest results in hemorrhagic shock. Crit Care. 2008;12:218. [PMC free article] [PubMed] [Google Scholar]

17. Eberst ME. Blood transfusions and component therapy. In: Tintinalli JE, Kelen GD, Stapczynski JS, editors. A Comprehensive study guide. 5th ed. New York: Mc Graw Hill; 2000. pp. 1392–9. [Google Scholar]

18. Schwab CW, Civil I, Shayne JP. Saline expanded group O uncrossmatched packed red blood cells as an initial resuscitation fluid in severe shock. Ann Emerg Med. 1986;15:1282–7. [PubMed] [Google Scholar]

19. Gin Shaw SL, Jorden RC. Multiple trauma. In: Marx JA, editor. Rosen’s emergency medicine. Concepts and clinical practice. 5th ed. St Louis: Mosby Inc; 2002. pp. 242–55. [Google Scholar]

20. Meng ZH, Wolberg AS, Monroe DM, 3rd, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high dose factor VIIa in hypothermic and acidotic patients. J Trauma. 2003;55:886–91. [PubMed] [Google Scholar]

21. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med. 2006;16:31–9. [PubMed] [Google Scholar]

22. Orlin JB, Berkman EM. Partial plasma exchange using albumin replacement: Removal and recovery of normal plasma constituents. Blood. 1980;56:1055–9. [PubMed] [Google Scholar]

23. Hughes GS, Jr, Yancey EP, Albrecht R, Locker PK, Francom SF, Orringer EP, et al. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans. Clin Pharmacol Ther. 1995;58:434–43. [PubMed] [Google Scholar]

24. Hughes GS, Jr, Francome SF, Antal EJ, Adams WJ, Locker PK, Yancey EP, et al. Hematologic effects of a novel hemoglobin based oxygen carrier in normal male and female subjects. J Lab Clin Med. 1995;126:444–51. [PubMed] [Google Scholar]

25. Levy JH, Goodnough LT, Greilich PE, Parr GV, Stewart RW, Gratz I, et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomised double blind trial. J Thorac Cardiovasc Surg. 2002;124:35–42. [PubMed] [Google Scholar]

26. Kerner T, Ahlers O, Veit S, Riou B, Saunders M, Pison U. DCL-Hemoglobin for trauma patients with severe hemorrhagic shock: the European ‘on scene’ multicenter study. Intensive Care Med. 2003;29:378–85. [PubMed] [Google Scholar]

27. Scharte M, Fink MP. Red blood cell physiology in critical illness. Crit Care Med. 2003;31:651–7. [PubMed] [Google Scholar]

28. Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, et al. High dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma. 1998;44:361–7. [PubMed] [Google Scholar]

29. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized control trial. JAMA. 2002;288:2837–45. [PubMed] [Google Scholar]

30. Stubbs JR. Alternatives to blood product transfusion in the critically ill:erythropoietin. Crit Care Med. 2006;34:160–9. [PubMed] [Google Scholar]

31. Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, et al. EPO Critical Care Trials Group. Efficacy and safety of epoietin alfa in critically ill patients. N Engl J Med. 2007;357:965–76. [PubMed] [Google Scholar]

32. Victorino G, Wisner DH. Jehovah’s Witnesses: unique problems in a unique trauma population. J Am Coll Surg. 1997;184:458–68. [PubMed] [Google Scholar]

33. Murphy DP, O’Donnell T, Mc Donnell J, Mc Elwain JP. Treatment of anemia in the polytrauma Jehovah’s Witness. Ir Med J. 2003;96:8–10. [PubMed] [Google Scholar]

34. Kasper CK, Lusher JM. Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion practices committee. Transfusion. 1993;33:422–34. [PubMed] [Google Scholar]

35. Gorgas DL. Transfusion therapy: blood and blood products. In: Robert JR, Hedges JR, editors. Clinical procedures in emergency medicine. 4th ed. Philadelphia: Elsevier; 2004. pp. 513–30. [Google Scholar]

36. Ketchum L, Hess, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate and platelet transfusion in trauma. J Trauma. 2006;60:51–8. [PubMed] [Google Scholar]

37. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double blind placebo controlled randomized trial. Lancet. 2003;361:201–5. [PubMed] [Google Scholar]

38. Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, et al. NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005;59:8–15. [PubMed] [Google Scholar]

39. Klitgaard T, Tabanera Y, Palacios R, Boffard KD, Iau PT, Warren B, et al. NovoSeven Trauma Study Group. Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding. Crit Care. 2006;10:R104. [PMC free article] [PubMed] [Google Scholar]

40. Mannucci PM, Canciani MT, Rota L, Donovan BS. Response of factor VIII/von Williebrand factor to DDAVP in healthy subjects and patients with hemophilia A and von Williebrand’s disease. Br J Hematol. 1981;47:283–93. [PubMed] [Google Scholar]

41. Brecher ME, editor. Adverse effects of Blood Transfusion In: Technical Manual. 15th ed. Bethesda MD: American Association of Blood Banks; 2005. American Association of Blood Banks. [Google Scholar]

42. Como JJ, Dutton RP, Scalea TJ, Edelman BB, Hess JR. Blood transfusion rates in the care of acute trauma. Transfusion. 2004;44:809–13. [PubMed] [Google Scholar]

43. Committee on Trauma American College of Surgeons: Advanced trauma life support programme for doctors. 6th ed. Chicago III: American College of Surgeons; 1997. [Google Scholar]

44. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfus Med Rev. 2003;17:223–31. [PubMed] [Google Scholar]

45. Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth. 2005;95:130–9. [PubMed] [Google Scholar]

46. Practice guidelines for blood component therapy Report by the American society of Anesthesiologists Task Force on blood component therapy. Anesthesiology. 1996;84:732–47. [PubMed] [Google Scholar]

47. Development Task Force of the College of American Pathologists Practice parameter for the use of fresh frozen plasma, cryoprecipitate and platelets. JAMA. 1994;271:777–81. [PubMed] [Google Scholar]

48. Ciavarella D, Reed L, Counts RB, Baron L, Pavlin E, Heimbach DM, et al. Clotting factors and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Hematol. 1987;67:365–8. [PubMed] [Google Scholar]

49. Borgman MA, Spinella PC, Perkins JG, Grathwol KW, Repine T, Beekly AC, et al. the ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805–13. [PubMed] [Google Scholar]

50. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA. A high ratio of plasma and platelets to packed red blood cells in the first six hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg. 2009;197:565–70. [PubMed] [Google Scholar]

51. Shah BH, Dente CJ, Harris RS, MacLeod JB, Hillyer CD. Transfusion management of trauma patients. Anesth Analg. 2009;108:1760–8. [PMC free article] [PubMed] [Google Scholar]